Contact
The main French newspaper Le Monde echoes the research performed at IRB Barcelona on the side effects of drugs. Patrick Aloy and Miquel Duran provide molecular hypotheses for 1,162 secondary effects caused by around 1,000 drugs. Aloy and Duran have listed a series of "alerts" so as to enable medical chemists to circumvent many of these effects when designing new drugs. The results of this study were recently published in the scientific journal Chemistry and Biology, which belongs to the Cell group.
Read news in Le Monde (PDF in French)
Link to Le Monde
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
